Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201101749 Principal Investigator: Vij, Ravi
Title: Phase I/II Trial of Azacitidine plus Lenalidomide in the Treatment of Acute Myeloid Leukemia
Phase: I/II Disease Site: Myeloid and Monocytic Leukemia
Participating Site(s):
 
Main Campus
Map and Directions		 South County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this study is to test the safety of the combination of various dose levels of lenalidomide and azacitidine in patients with AML. This research is being done because the current chemotherapy options for AML in patient 60 years and above and in patients in whom the AML has not responded or has returned after the first line chemotherapy are not very effective.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)